Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion.
暂无分享,去创建一个
[1] W. Jusko,et al. Plasma protein binding of tacrolimus in humans. , 1993, Journal of pharmaceutical sciences.
[2] N. Rifai,et al. The role of lipoproteins in the transport and uptake of cyclosporine and dihydro-tacrolimus into HepG2 and JURKAT cell lines. , 1996, Clinical biochemistry.
[3] K. Iwasaki,et al. Pharmacokinetic study of FK 506 in the rat. , 1991, Transplantation proceedings.
[4] Wojciech Piekoszewski,et al. Pharmacokinetics of tacrolimus in liver transplant patients , 1995, Clinical pharmacology and therapeutics.
[5] K. Takada,et al. Pharmacokinetics of FK-506, a novel immunosuppressant, after intravenous and oral administrations to rats. , 1991, Journal of pharmacobio-dynamics.
[6] W. Jusko,et al. Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance. , 1993, Drug metabolism and disposition: the biological fate of chemicals.
[7] Nolan H. Sigal,et al. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin , 1989, Nature.
[8] J J Fung,et al. Pharmacokinetics of FK 506: preclinical and clinical studies. , 1990, Transplantation proceedings.
[9] S. Todo,et al. Intestinal transplantation in humans under FK 506. , 1993, Transplantation proceedings.
[10] S. Takahara,et al. Use of FK 506 in kidney transplantation. , 1993, Transplantation proceedings.
[11] T. Guentert,et al. Comparison of Equilibrium Times in Dialysis Experiments Using Spiked Plasma or Spiked Buffer , 1982 .
[12] S. Takahara,et al. Effect of temperature and hematocrit on plasma concentration of FK 506. , 1991, Transplantation proceedings.
[13] T. Starzl,et al. Strategy of FK 506 therapy in liver transplant patients: effect of graft function. , 1991, Transplantation proceedings.
[14] J. Kay,et al. Uptake of FK 506 by lymphocytes and erythrocytes. , 1991, Transplantation proceedings.
[15] W. Jusko,et al. Monitoring FK 506 concentrations in plasma and whole blood. , 1991, Transplantation proceedings.
[16] W. Jusko,et al. Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits. , 1994, The Journal of pharmacology and experimental therapeutics.
[17] C. Groth,et al. Pharmacokinetics of FK 506 during maintenance therapy in liver transplant patients. , 1991, Transplantation proceedings.
[18] L. Dubé,et al. Comparison of the erythrocyte partitioning method with two classical methods for estimating free drug fraction in plasma. , 1984, Biopharmaceutics & drug disposition.
[19] T. Starzl,et al. Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. , 1992, Transplantation proceedings.
[20] Mangan Kf. Immunologic control of hemopoiesis: implications for quality of the graft after allogeneic bone marrow transplantation. , 1987 .
[21] M. Kobayashi,et al. A highly sensitive method to assay FK-506 levels in plasma. , 1987, Transplantation proceedings.